Dolat Capital: Sun Pharma’s  Investments To Build A Branded Specialty Business - A Key Differentiator
Signage is displayed at the Sun Pharmaceutical Industries Ltd. headquarters in Mumbai, India. (Photographer: Kanishka Sonthalia/Bloomberg)

Dolat Capital: Sun Pharma’s  Investments To Build A Branded Specialty Business - A Key Differentiator

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportun...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.